Completed NA INTERVENTIONAL 2-arm NCT06453837

Clinical Study for the Efficacy Evaluation of a Food Supplement

Double Blinded Randomized Placebo Controlled Clinical Study for the Evaluation of the Efficacy of One Active Ingredient Incorporated Into a Food Supplement

Sponsor: Inovapotek, Pharmaceutical Research And Development Lda

Conditions Spot Pigmented Wrinkle

Interventions Mentha Suaveolens extract incorporated into a food supplement Placebo product

Updated 2 times since 2024 Last updated: Jun 5, 2024 Started: Jun 21, 2023 Primary completion: Dec 21, 2023 Completion: Mar 8, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Spot Pigmented and Wrinkle and is currently completed. Inovapotek, Pharmaceutical Research And Development Lda leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Inovapotek, Pharmaceutical Research And Development Lda
Mibelle Group Biochemistry

Data source: Mibelle Group Biochemistry

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porto, Portugal